Analysis of Intermediate Term Results of Short Vein Bypass Graft in the Patient with Critical Limb Ischemia
- PMID: 26217612
- PMCID: PMC4480299
- DOI: 10.5758/vsi.2014.30.1.26
Analysis of Intermediate Term Results of Short Vein Bypass Graft in the Patient with Critical Limb Ischemia
Abstract
Purpose: Since the introduction of short vein bypass (SVB), many have reported its feasibility when long vein bypass (LVB) cannot be performed due to limited vein conduit. However, the presence of inflow-vessel disease may affect graft patency and thus require endovascular treatment prior to surgery. Our study aims to analyze the results between SVB and LVB.
Materials and methods: From 2009 to 2013, 27 bypass procedures were reviewed retrospectively. Outcomes such as patency rate, postoperative ankle brachial index (ABI) and limb salvage rate between SVB and LVB were compared. Wound healing time and primary patency rate were analyzed and the former was also analyzed according to the respective angiosome and revascularization type.
Results: There were 11 males and 16 females and the mean age was 66.6±12.3 years. Twenty four patients had TransAtlantic Inter-Society Consensus (TASC) D and 3 patients had TASC C lesions below knee. The 1-year cumulative patency rate between SVB and LVB were 63% and 66%, P=0.627. The limb salvage rate (100% vs. 73%; P=0.280) and postoperative ABI (0.592 vs. 0.508; P=0.620) were higher in the SVB group than in the LVB group, although the differences were not significant. There was no difference in wound healing time by angiosomal revascularization type. In situ vein graft showed higher patency rate than reversed greater saphenous vein (75% vs. 61%; P=0.00).
Conclusion: The results of SVB were similar to those of LVB. SVB is feasible in the setting of limited conduit availability, in combination with endovascular treatment in the presence of proximal lesions.
Keywords: Angiosome; Bypass; Distal.
Figures
Similar articles
-
Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure.J Vasc Surg. 2014 Jul;60(1):129-35. doi: 10.1016/j.jvs.2014.01.013. Epub 2014 Mar 7. J Vasc Surg. 2014. PMID: 24613692
-
Effects of endovascular first strategy on spliced vein bypass outcomes.J Vasc Surg. 2020 Mar;71(3):880-888. doi: 10.1016/j.jvs.2019.05.055. Epub 2019 Sep 26. J Vasc Surg. 2020. PMID: 31564580
-
Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass.J Vasc Surg. 2012 Apr;55(4):1008-14. doi: 10.1016/j.jvs.2011.11.042. Epub 2012 Feb 24. J Vasc Surg. 2012. PMID: 22365176
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):126S-136S. doi: 10.1016/j.jvs.2018.01.071. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159976
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S110-S119. doi: 10.1016/j.ejvs.2019.04.013. Epub 2019 Jun 17. Eur J Vasc Endovasc Surg. 2019. PMID: 31221539
Cited by
-
Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention.J Vasc Surg. 2017 Oct;66(4):1109-1116.e1. doi: 10.1016/j.jvs.2017.04.036. Epub 2017 Jun 24. J Vasc Surg. 2017. PMID: 28655549 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources